The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Changes in frailty are associated with waitlist mortality in patients with cirrhosis
Open accessAbstract
Background & Aims Frailty is predictive of death in patients with cirrhosis, but studies to date have been limited to assessments at a single time point. We aimed to evaluate changes in frailty over time (ΔLFI) and its association with death/delisting for sickness. Methods Adults with cirrhosis listed for liver transplantation without hepatocellular carcinoma at 8 U.S. centers underwent ambulatory longitudinal frailty testing with the Liver Frailty Index (LFI). We used multilevel linear mixed effects regression to model and predict ΔLFI per 3 months based on age, gender, MELDNa, ascites, and hepatic encephalopathy (HE) and categorize patients by frailty trajectories. Competing risk regression evaluated the subhazard ratio (sHR) of baseline LFI and predicted ΔLFI on death/delisting, with transplantation as the competing risk. Results We analyzed 2,851 visits from 1,093 outpatients with cirrhosis. Patients with severe frailty worsening had worse baseline LFI and were more likely to have NAFLD, diabetes, or dialysis-dependence. After a median follow-up of 11 months, 223 (20%) of the overall cohort died/were delisted for sickness. The cumulative incidence of death/delisting increased by worsening ΔLFI group. In competing risk regression adjusted for baseline LFI, age, height, MELDNa, and albumin, a 0.1 unit change in ΔLFI per 3 months was associated with a 2.04-fold increased risk of death/delisting (95% CI, 1.35–3.09). Conclusion Changes in frailty were significantly associated with death/delisting independent of baseline frailty and MELDNa. Notably, patients who experienced improvements in frailty over time had a lower risk of death/delisting than those who experienced worsening frailty. Our data support the longitudinal measurement of frailty, using the LFI, in patients with cirrhosis and lay the foundation for interventional work aimed at reversing frailty.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290 · cited 1×
“Then we modeled the cumulative incidence function with Fine and Gray competing risk regressions to estimate the risk of waitlist mortality associated with each variable.[11] Risk estimates were described as subhazard ratios (sHR) with 95% confidence intervals (CI).”
MethodGuralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Development of a novel frailty index to predict mortality in patients with end‐stage liver disease
Lai, J. C., Covinsky, K. E., Dodge, J. L., Boscardin, W. J., Segev, D. L., Roberts, J. P., & Feng, S. (2017) · Hepatology · doi:10.1002/hep.29219 · Cited by 556 · cited 2×
“[1] Consisting of grip strength, chair stands, and balance testing, the LFI can predict mortality among patients with cirrhosis awaiting liver transplantation above and beyond traditional metrics of liver disease severity (such as the Model for EndStage Liver Disease (MELDNa) score or the presence of ascites / hepatic…”
BackgroundSelf-citation
Cited by
Lai, J. C., Tandon, P., Bernal, W., Tapper, E. B., Ekong, U., Dasarathy, S., & Carey, E. J. (2021) · Hepatology · doi:10.1002/hep.32049 · Cited by 742
Self-citationSarcopenia and frailty in decompensated cirrhosis
Tandon, P., Montano-Loza, A. J., Lai, J. C., Dasarathy, S., & Merli, M. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.025 · Cited by 408
Self-citationEASL Clinical Practice Guidelines on liver transplantation
Samuel, D., De Martin, E., Berg, T., Berenguer, M., Burra, P., Fondevila, C., Heimbach, J. K., Pageaux, G.-P., Sanchez-Fueyo, A., & Toso, C. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.07.032 · Cited by 263
Solà, E., Pose, E., Campion, D., Piano, S., Roux, O., Simon-Talero, M., Uschner, F., de Wit, K., Zaccherini, G., Alessandria, C., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.009 · Cited by 41
“160,161 Other assessments In trials evaluating new strategies for the management of patients with decompensated cirrhosis the evaluation of cost-effectiveness is also important (see supplementary material).”
Metadata
- Authors
- Lai, J. C., Dodge, J. L., Kappus, M. R., Dunn, M. A., Volk, M. L., Duarte-Rojo, A., Ganger, D. R., Rahimi, R. S., McCulloch, C. E., Haugen, C. E., McAdams-DeMarco, M., Ladner, D. P., Segev, D. L., & Verna, E. C.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2020-09
- Volume
- 73
- Issue
- 3
- Pages
- 575-581
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W3013201125
- Cited by
- 159
- References
- 3
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Changes in frailty are associated with waitlist mortality in patients with cirrhosis. https://app.cochat.ai/papers/10.1016/j.jhep.2020.03.029
- The paper
- Lai, J. C., Dodge, J. L., Kappus, M. R., Dunn, M. A., Volk, M. L., Duarte-Rojo, A., Ganger, D. R., Rahimi, R. S., McCulloch, C. E., Haugen, C. E., McAdams-DeMarco, M., Ladner, D. P., Segev, D. L., & Verna, E. C. (2020). Changes in frailty are associated with waitlist mortality in patients with cirrhosis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2020.03.029
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.